Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan; Centre of Clinical Infectious Disease and Research, Saitama Medical University, Saitama, Japan.
Department of Infectious Disease and Infection Control, Saitama Medical University, Saitama, Japan; Centre of Clinical Infectious Disease and Research, Saitama Medical University, Saitama, Japan.
J Hosp Infect. 2020 Aug;105(4):615-618. doi: 10.1016/j.jhin.2020.05.025. Epub 2020 May 22.
With the emergence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), a high-speed and convenient detection technology should be at the forefront of medical care worldwide. This study evaluated the usefulness of GeneSoC, a compact, high-speed reciprocal flow quantitative reverse transcription polymerase chain reaction system, for the detection of SARS-CoV-2. The results support the use of this system for the rapid identification of SARS-CoV-2. This approach can contribute to the strategic selection of initial management strategies for patients with COVID-19.
随着严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）的出现，这种病毒会导致 2019 年冠状病毒病（COVID-19），一种高速便捷的检测技术应该成为全球医疗保健的前沿。本研究评估了 GeneSoC 的有用性，它是一种紧凑、高速的对流定量逆转录聚合酶链反应系统，用于检测 SARS-CoV-2。结果支持该系统用于快速识别 SARS-CoV-2。这种方法可以为 COVID-19 患者的初始管理策略的选择提供帮助。
